Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update
Go back to Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 59.35 -4.61 (7.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.96 | 52 Week High | $0.52 | |||
| Open | $64.07 | 52 Week Low | $0.08 | |||
| Day High | $65.51 | P/E | N/A | |||
| Day Low | $57.50 | EPS | $-3.80 | |||
| Volume | 8,310,041 | |||||
